A novel tumor-targeting treatment strategy uses energy restriction via co-delivery of albendazole and nanosilver
Crossref DOI link: https://doi.org/10.1007/s12274-018-2032-x
Published Online: 2018-03-16
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liang, Jianming
Li, Ruixiang
He, Yuwei
Ling, Chengli
Wang, Qi
Huang, Yongzhuo
Qin, Jing
Lu, Weigen
Wang, Jianxin
Text and Data Mining valid from 2018-03-16
Article History
Received: 4 January 2018
Revised: 19 February 2018
Accepted: 20 February 2018
First Online: 16 March 2018